• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health.

作者信息

Chial H J, Camilleri C, Delgado-Aros S, Burton D, Thomforde G, Ferber I, Camilleri Michael

机构信息

Clinical Enteric, Neuroscience, Translational and Epidemiological Research Program, Gastroenterology Research Unit, Mayo Clinic Rochester, Rochester, MN, USA.

出版信息

Neurogastroenterol Motil. 2002 Jun;14(3):249-53. doi: 10.1046/j.1365-2982.2002.00326.x.

DOI:10.1046/j.1365-2982.2002.00326.x
PMID:12061909
Abstract

To assess the effects of age, gender and body mass index on the maximum tolerated volume of a nutrient drink and postprandial symptoms in health. Healthy adolescents (15 M, 15 F, aged 13-17 years) and adults (15 M, 25 F, aged 19-51 years) ingested Ensure (1 kcal mL-1) at a rate of 30 mL min-1. The maximum tolerated volume was recorded. Thirty minutes later, bloating, fullness, nausea and pain were rated using visual analogue scales. The Mann-Whitney test was used for comparisons between groups using body mass index and maximum tolerated volume as covariates. Age-related differences in maximum tolerated volume were noted between adolescents and adults, and were observed in both genders. Adults had higher scores for bloating and pain, and lower scores for fullness. Gender-related differences in maximum tolerated volume were noted in the group as a whole, and separately for adolescents and adults. Females had higher scores for nausea and pain. Gender and age-related differences in the maximum tolerated volume of a nutrient drink and postprandial symptoms should be considered in future studies of upper gastrointestinal symptoms in disease. Body mass index does not appear to influence maximum tolerated volume beyond its association with age and gender.

摘要

相似文献

1
A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health.
Neurogastroenterol Motil. 2002 Jun;14(3):249-53. doi: 10.1046/j.1365-2982.2002.00326.x.
2
Satiety drinking tests: effects of caloric content, drinking rate, gender, age, and body mass index.饱腹感饮水测试:热量含量、饮水速度、性别、年龄和体重指数的影响
Scand J Gastroenterol. 2009;44(5):551-6. doi: 10.1080/00365520902767546.
3
Relationship of gastric emptying or accommodation with satiation, satiety, and postprandial symptoms in health.健康状态下胃排空或胃容受性与饱腹感、饱足感及餐后症状的关系。
Am J Physiol Gastrointest Liver Physiol. 2017 Nov 1;313(5):G442-G447. doi: 10.1152/ajpgi.00190.2017. Epub 2017 Aug 3.
4
Effects of 5-HT(3) antagonism on postprandial gastric volume and symptoms in humans.5-羟色胺(3)拮抗剂对人体餐后胃容量及症状的影响。
Aliment Pharmacol Ther. 2002 Feb;16(2):225-33. doi: 10.1046/j.1365-2036.2002.01144.x.
5
Independent influences of body mass and gastric volumes on satiation in humans.体重和胃容量对人类饱腹感的独立影响。
Gastroenterology. 2004 Feb;126(2):432-40. doi: 10.1053/j.gastro.2003.11.007.
6
Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant.NK1受体对健康人胃运动功能及饱腹感的影响:NK1拮抗剂阿瑞匹坦对照试验的结果
Am J Physiol Gastrointest Liver Physiol. 2017 Nov 1;313(5):G505-G510. doi: 10.1152/ajpgi.00197.2017. Epub 2017 Aug 16.
7
Nutrient drink test: A promising new tool for irritable bowel syndrome diagnosis.营养饮料测试:诊断肠易激综合征的有前途的新工具。
World J Gastroenterol. 2019 Feb 21;25(7):837-847. doi: 10.3748/wjg.v25.i7.837.
8
Dietary influence on electro-gastrography and association of alterations in gastric myoelectrical activity with symptoms in patients with functional dyspepsia.饮食对胃电图的影响以及功能性消化不良患者胃肌电活动改变与症状的关联
J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):59-64. doi: 10.1111/j.1440-1746.2005.04088.x.
9
Paired comparison between water and nutrient drink tests in healthy volunteers.健康志愿者中水分与营养饮品测试的配对比较。
Arq Gastroenterol. 2009 Oct-Dec;46(4):304-10. doi: 10.1590/s0004-28032009000400011.
10
Effect of somatostatin analog on postprandial satiation in obesity.生长抑素类似物对肥胖症患者餐后饱腹感的影响。
Obes Res. 2005 Sep;13(9):1572-9. doi: 10.1038/oby.2005.193.

引用本文的文献

1
Broader Validation of New Zealand Eating Behavior Questionnaire as Clinical Assessment Tool to Identify Actionable Eating Behavior Traits.将新西兰饮食行为问卷作为临床评估工具以识别可采取行动的饮食行为特征的更广泛验证
Nutrients. 2025 Mar 17;17(6):1049. doi: 10.3390/nu17061049.
2
The melanocortin-4 receptor pathway and the emergence of precision medicine in obesity management.黑素皮质素 4 受体途径与肥胖管理中精准医学的出现。
Diabetes Obes Metab. 2024 Apr;26 Suppl 2(Suppl 2):46-63. doi: 10.1111/dom.15555. Epub 2024 Mar 19.
3
Neurohormonal response patterns to hunger, satiation, and postprandial fullness in normal weight, anorexia nervosa, and obesity.
正常体重、神经性厌食症和肥胖患者的饥饿、饱腹感和餐后饱满感的神经激素反应模式。
Neurogastroenterol Motil. 2024 Jan;36(1):e14695. doi: 10.1111/nmo.14695. Epub 2023 Nov 5.
4
Abnormal gastrointestinal motility is a major factor in explaining symptoms and a potential therapeutic target in patients with disorders of gut-brain interaction.异常的胃肠道动力是解释症状的一个主要因素,也是治疗肠-脑相互作用障碍患者的一个潜在治疗靶点。
Gut. 2023 Nov 24;72(12):2372-2380. doi: 10.1136/gutjnl-2023-330542.
5
A Randomized, Controlled Trial of Efficacy and Safety of Cannabidiol in Idiopathic and Diabetic Gastroparesis.一项随机、对照试验研究了大麻二酚在特发性和糖尿病性胃轻瘫中的疗效和安全性。
Clin Gastroenterol Hepatol. 2023 Dec;21(13):3405-3414.e4. doi: 10.1016/j.cgh.2023.07.008. Epub 2023 Jul 22.
6
Nutrient Drink Test to Assess Gastric Accommodation in Cyclic Vomiting Syndrome: Single-blinded Parallel Grouped Prospective Study.营养饮料测试评估周期性呕吐综合征中的胃容纳功能:单盲平行分组前瞻性研究。
J Neurogastroenterol Motil. 2023 Jan 30;29(1):65-71. doi: 10.5056/jnm22013.
7
Sex as an independent variable in the measurement of satiation: a retrospective cohort study.将性作为饱腹感测量中的一个独立变量:一项回顾性队列研究。
Int J Obes (Lond). 2022 Dec;46(12):2156-2162. doi: 10.1038/s41366-022-01228-7. Epub 2022 Oct 13.
8
Factors associated with successful weight loss after liraglutide treatment for obesity.与利拉鲁肽治疗肥胖症后成功减肥相关的因素。
Diabetes Obes Metab. 2023 Feb;25(2):377-386. doi: 10.1111/dom.14880. Epub 2022 Oct 24.
9
Effects of liraglutide on gastrointestinal functions and weight in obesity: A randomized clinical and pharmacogenomic trial.利拉鲁肽对肥胖患者胃肠功能和体重的影响:一项随机临床和药物基因组学试验。
Obesity (Silver Spring). 2022 Aug;30(8):1608-1620. doi: 10.1002/oby.23481.
10
Precision Medicine and Obesity.精准医学与肥胖症。
Handb Exp Pharmacol. 2022;274:467-485. doi: 10.1007/164_2021_566.